Alkylating agents

Juris Germanas, Amit G. Pandya

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Alkylating agents have been used for many years for their antineoplastic and immunosuppressive properties. In recent years, alkylating agents have found utility in various nononcology applications, particularly in the treatment of autoimmune diseases, due to their ability to suppress humoral and cell-mediated immunity. Dermatologic applications of alkylating agents have also been increasing. This article presents the basic pharmacologic properties of the two most commonly used alkylating agents in dermatology, cyclophosphamide and chlorambucil. Recent applications of these two agents in the treatment of autoimmune blistering diseases are also reviewed.

Original languageEnglish (US)
Pages (from-to)317-324
Number of pages8
JournalDermatologic Therapy
Volume15
Issue number4
DOIs
StatePublished - 2002

Fingerprint

Alkylating Agents
Autoimmune Diseases
Chlorambucil
Immunosuppressive Agents
Dermatology
Cellular Immunity
Antineoplastic Agents
Cyclophosphamide

Keywords

  • Chlorambucil
  • Cyclophosphamide

ASJC Scopus subject areas

  • Dermatology

Cite this

Germanas, J., & Pandya, A. G. (2002). Alkylating agents. Dermatologic Therapy, 15(4), 317-324. https://doi.org/10.1046/j.1529-8019.2002.01540.x

Alkylating agents. / Germanas, Juris; Pandya, Amit G.

In: Dermatologic Therapy, Vol. 15, No. 4, 2002, p. 317-324.

Research output: Contribution to journalArticle

Germanas, J & Pandya, AG 2002, 'Alkylating agents', Dermatologic Therapy, vol. 15, no. 4, pp. 317-324. https://doi.org/10.1046/j.1529-8019.2002.01540.x
Germanas, Juris ; Pandya, Amit G. / Alkylating agents. In: Dermatologic Therapy. 2002 ; Vol. 15, No. 4. pp. 317-324.
@article{ac0e0765e0da429ab0f8fafe006e4b82,
title = "Alkylating agents",
abstract = "Alkylating agents have been used for many years for their antineoplastic and immunosuppressive properties. In recent years, alkylating agents have found utility in various nononcology applications, particularly in the treatment of autoimmune diseases, due to their ability to suppress humoral and cell-mediated immunity. Dermatologic applications of alkylating agents have also been increasing. This article presents the basic pharmacologic properties of the two most commonly used alkylating agents in dermatology, cyclophosphamide and chlorambucil. Recent applications of these two agents in the treatment of autoimmune blistering diseases are also reviewed.",
keywords = "Chlorambucil, Cyclophosphamide",
author = "Juris Germanas and Pandya, {Amit G.}",
year = "2002",
doi = "10.1046/j.1529-8019.2002.01540.x",
language = "English (US)",
volume = "15",
pages = "317--324",
journal = "Dermatologic Therapy",
issn = "1396-0296",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Alkylating agents

AU - Germanas, Juris

AU - Pandya, Amit G.

PY - 2002

Y1 - 2002

N2 - Alkylating agents have been used for many years for their antineoplastic and immunosuppressive properties. In recent years, alkylating agents have found utility in various nononcology applications, particularly in the treatment of autoimmune diseases, due to their ability to suppress humoral and cell-mediated immunity. Dermatologic applications of alkylating agents have also been increasing. This article presents the basic pharmacologic properties of the two most commonly used alkylating agents in dermatology, cyclophosphamide and chlorambucil. Recent applications of these two agents in the treatment of autoimmune blistering diseases are also reviewed.

AB - Alkylating agents have been used for many years for their antineoplastic and immunosuppressive properties. In recent years, alkylating agents have found utility in various nononcology applications, particularly in the treatment of autoimmune diseases, due to their ability to suppress humoral and cell-mediated immunity. Dermatologic applications of alkylating agents have also been increasing. This article presents the basic pharmacologic properties of the two most commonly used alkylating agents in dermatology, cyclophosphamide and chlorambucil. Recent applications of these two agents in the treatment of autoimmune blistering diseases are also reviewed.

KW - Chlorambucil

KW - Cyclophosphamide

UR - http://www.scopus.com/inward/record.url?scp=0036969584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036969584&partnerID=8YFLogxK

U2 - 10.1046/j.1529-8019.2002.01540.x

DO - 10.1046/j.1529-8019.2002.01540.x

M3 - Article

AN - SCOPUS:0036969584

VL - 15

SP - 317

EP - 324

JO - Dermatologic Therapy

JF - Dermatologic Therapy

SN - 1396-0296

IS - 4

ER -